mardi 8 mars 2016

Onco Actu du 8 mars 2016

1. Biologie

How cancer cells fuel their growth [MIT News]

When prostate cancer spreads, where it goes matters [STAT]

How the US CRISPR patent probe will play out [Nature News & Comment]

CRISPR: gene editing is just the beginning [Nature News & Comment]

2.6 Etiologie - Environnement

EU to defer decision on safety of weed-killer ingredient: sources [Reuters]

3.3 Prévention - Vaccins

Gardasil 9 [EMA]

4.13 Dép., diag. & prono. - Peau

Blood test may give early warning of skin cancer relapse [Cancer Research UK]

4.2 Dép., diag. & prono. - Génome

Illumina CEO Jay Flatley Built The DNA Sequencing Market. Now He's Stepping Down [Forbes]

4.9 Dép., diag. & prono. - Sein

ESMO Open Press Release: High White Blood Cell Ratio Linked to Recurrence Risk in Early Stage Breast Cancer [ESMO]

5. Traitements

Long learning curve for surgeons operating on oesophageal cancer [Karolinska Institutet]

5.2 Pharma

Celldex (CLDX) Brain Tumor Vaccine Fails Pivotal Clinical Trial [TheStreet]

Celldex discontinues late-stage study of brain cancer vaccine [Reuters]

5.2.3 Pharma - économie

With $70M in VC cash, Tizona takes a fresh approach to immuno-oncology [FierceBiotech]

Argos Nabs Up to $60M to Continue Kidney Cancer Treatment Work [Xconomy]

5.3 Traitements - FDA, EMA,...

Regulators, Industry Weigh in on Proposed EU Orphan Regulation Changes [RAPS]

EMA Looks to Accelerate New Therapies Targeting Unmet Needs [RAPS]

Launch of PRIME - Paving the way for promising medicines for patients [EMA]

Europe launches new fast approval scheme for promising drugs [Reuters]

6.1 Observation

UK diagnoses children’s kidney cancer at a later stage than Germany [Cancer Research UK]

6.6 Publications

Can Scopus Deliver A Better Journal Impact Metric? Response from Scopus [The Scholarly Kitchen]

Can Scopus Deliver A Better Journal Impact Metric? [The Scholarly Kitchen]

6.8 Communication

FOX, Banner MD Anderson hype Cuba cancer "breakthrough" []

6.9 Controverses

Statisticians Found One Thing They Can Agree On: It’s Time To Stop Misusing P-Values [FiveThirtyEight]

We’re using a common statistical test all wrong. Statisticians want to fix that. [Retraction Watch]

Statisticians issue warning over misuse of P values [Nature News & Comment]